Risedronate Sodium Tablets USP 30mg Technical Specification:
| Product Name: | Risedronate Sodium Tablets USP 30mg |
| Brand Name: | Generic |
| Strength: | (5mg), (30mg), (35mg), (150mg) |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Antiosteoporotic |
| Indication: | Risedronate is for use when you have a high risk of bone fracture due to osteoporosis. |
| Storage: | Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Risedronate Sodium Tablets USP 5mg
- Risedronate Sodium Tablets USP 30mg
- Risedronate Sodium Tablets USP 35mg
- Risedronate Sodium Tablets USP 150mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Risedronate Sodium Tablets USP 5mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………5mg
Excipients ……………………………………………….q.s.
Colour: Caramel
- Risedronate Sodium Tablets USP 30mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………30mg
Excipients……………………………………………….q.s.
Colour: Ponceau 4 R
- Risedronate Sodium Tablets USP 35mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………35mg
Excipients ……………………………………………….q.s.
Colour: Titanium dioxide
- Risedronate Sodium Tablets USP 150mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………150mg
Excipients ……………………………………………….q.s.
Colour: Tartrazine yellow
THERAPEUTIC INDICATIONS:
Risedronate is used by adults to treat a disease that weakens bones (Paget’s disease). This medication helps to reduce bone pain and may prevent long-term complications from this disease. Risedronate works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). It belongs to a class of medications called bisphosphonates.
CAUTION & SCHEDULE:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A Endocrinologist/Rheumatologist/Gynecologist/Orthopedics.
STORAGE & DOSAGE:
Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Dosage: One tablet same day every week.
GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Risedronate Sodium Tablets USP 30mg
C) Risedronate Sodium Tablets USP 35mg
D) Risedronate Sodium Tablets USP 150mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………5mg
Excipients ……………………………………………….q.s.
Colour: Caramel
B) Risedronate Sodium Tablets USP 30mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………30mg
Excipients……………………………………………….q.s.
Colour: Ponceau 4 R
C) Risedronate Sodium Tablets USP 35mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………35mg
Excipients ……………………………………………….q.s.
Colour: Titanium dioxide
D) Risedronate Sodium Tablets USP 150mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate USP
Equivalent to Risedronate Sodium…………150mg
Excipients ……………………………………………….q.s.
Colour: Tartrazine yellow
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A ENDOCRINOLOGIST/RHEUMATOLOGIST/GYNECOLOGISTS/ORTHOPEDICS.
STORAGE & DOSAGE:
Dosage: One tablet same day every week.

